國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 909157      Online Users : 827
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Patents [0/42]
    Periodical Articles [141/141]
    Conference Papers/Meeting Abstract [30/48]

    Community Statistics


    Item counts issued in 3 years:13(5.63%)
    Items With Fulltext:171(74.03%)

    Download counts of the item
    Download times greater than 0:171(100.00%)
    Download times greater than 100:168(98.25%)
    Total Bitstream Download Counts:101892(1.90%)

    Last Update: 2024-12-01 04:23

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 51-75 of 231. (10 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2016-03 Disruption of protein-protein interactions: Hot spot detection, structure-based virtual screening and in vitro testing for the anti-cancer drug target survivin RSC Advances. 2016 Mar;6(38):31947-31959.
    2015-08 BPR2P001S0, a Coumarin derivative, induced cell cycle arrest in A549 through inhibiting PDPK1 activity Cancer Research. 2015 Aug;75:Abstract number 1754.
    2015-08 Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 490.
    2015-08 Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180.
    2015-08 Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 182.
    2015-07-31 作為極光激酶抑制劑的稠合雙環嘧啶化合物 HK1151694/2015-07-31
    2015-07-22 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 ZL200980144458.1/2015-07-22
    2015-06-29 Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification Scientific Reports. 2015 Jun 29;5:Article number 11702.
    2015-04-14 Fused multicyclic compounds as protein kinase inhibitors US9006252B2/2015-04-14
    2015-02 Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors Journal of Medicinal Chemistry. 2015 Feb;58(3):1452-1465.
    2015-01 Identification of ligand efficient, fragment-like hits from an HTS library: Structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity Journal of Computer-Aided Molecular Design. 2015 Jan;29(1):89-100.
    2014-12 BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71 Antiviral Research. 2014 Dec;112:18-25.
    2014-11 Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
    2014-11 CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors European Journal of Cancer. 2014 Nov;50(Suppl. 6):19-20.
    2014-10-29 作為極光激酶抑制劑的稠合雙環嘧啶化合物 ZL200980115577.4/2014-10-29
    2014-10-21 化合物於製造治療病毒感染的藥物之用途 I457121/2014-10-21
    2014-10 Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer Expert Opinion on Investigational Drugs. 2014 Oct;23(10):1333-1348.
    2014-10 Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 2530.
    2014-10 Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1756.
    2014-08 CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors International Journal of Cancer. 2014 Aug;135(3):751-762.
    2014-08 Ligand efficiency based approach for efficient virtual screening of compound libraries European Journal of Medicinal Chemistry. 2014 Aug;83:226-235.
    2014-07 Anaplastic lymphoma kinase (ALK) inhibitors: A review of design and discovery MedChemComm. 2014 Jul;5(9):1266-1279.
    2014-05 Facile identification of dual FLT3-Aurora A inhibitors: A computer-guided drug design approach ChemMedChem. 2014 May;9(5):953-961.
    2014-05 Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014) ChemMedChem. 2014 May;9(5):861.
    2014-04-29 Quinoline compounds and their use for treating viral infection US8710079B2/2014-04-29

    Showing items 51-75 of 231. (10 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback